Screening for primary aldosteronism: Implications of an increased plasma aldosterone/renin ratio

Clinical Chemistry

Volumn 48, Issue 11, 2002, Pages 1919-1923

  Schwartz, Gary L ^a   Chapman, Arlene B ^a   Boerwinkle, Eric ^a   Kisabeth, Robert M ^a   Turner, Stephen T ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; RENIN;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CAUCASIAN; DIAGNOSTIC VALUE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NEGRO; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; SENSITIVITY AND SPECIFICITY;

PIERINAE;

EID: 0036841187     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.11.1919     Document Type: Article

References (16)

1. Kaplan NM. Hypertension in the population at large. In: Kaplan NM, ed. Kaplan's Clinical Hypertension, 8th Ed. Philadelphia: Lippincott Williams & Wilkins, 2002:1-24.
2. Gordon RG, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharm Physiol 1994;21:315-8.
3. Brown MA, Cramp HA, Zammit VC, Whitworth JA. Primary aldosteronism: A missed diagnosis in 'essential hypertensives'? Aust NZ J Med 1996;26:533-8.
4. Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM. Potentially high prevalence of primary aldosteronism in a primary-care population [Letter]. Lancet 1999;353:40.
5. Weinberger MH, Fineberg NS. The diagnosis of primary aldosteronism and separation of two major subtypes. Arch Intern Med 1993;153:2125-2129.
6. Jose A, Kaplan NM. Plasma renin activity in the diagnosis of primary aldosteronism: Failure to distinguish primary aldosteronism from essential hypertension. Arch Intern Med 1969;123:141-6.
7. Kaplan NM. Cautions over the current epidemic of primary aldosteronism. Lancet 2001;357:953-4.
8. Helmer OM, Judson WE. Metabolic studies on hypertensive patients with suppressed plasma renin activity not due to hyperaldosteronism. Circulation 1968;38:965-76.
9. Channick BJ, Adlin EV, Marks AD. Suppressed plasma renin activity in hypertension. Arch Intern Med 1969;123:131-140.
10. Preston RA, Materson BJ, Reda DJ, Williams DW, Hamburger RJ, Cushman WC, et al. Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. JAMA 1998;280:1168-1172.
11. 3-subunit and antihypertensive response to a thiazide diuretic. Hypertension 2001;37(Part 2):739-43.
12. Melby JC. Diagnosis of hyperaldosteronism. Endocrinol Metab Clin North Am 1991;20:247-55.
13. Montori V, Schwartz GL, Chapman AB, Boerwinkle E, Turner ST. Validity of the aldosterone-renin ratio used to screen for primary aldosteronism. Mayo Clin Proc 2001;76:877-82.
14. Torpy D, Stratakis CA, Chrousos GP. Hyper- and hypo-aldosteronism. Vitam Horm 1999;46:177-216.
15. Young WF Jr. Primary aldosteronism - A common and curable form of hypertension. Cardiol Rev 1999;7:207-14.
16. Bravo EL, Tarazi RC, Dustan HP Fouad FM, Textor SC, Gifford RW, et al. The changing clinical spectrum of primary aldosteronism. Am. J Med 1983;74:641-50.